Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Sorafenib and dacarbazine as first-line therapy for advanced melanoma: phase I and open-label phase II studies.
Br J Cancer. 2011 Jul 26;105(3):353-9. doi: 10.1038/bjc.2011.257. Epub 2011 Jul 12.
Br J Cancer. 2011.
PMID: 21750549
Free PMC article.
Clinical Trial.
A phase I/II study of lomustine and temozolomide in patients with cerebral metastases from malignant melanoma.
Larkin JM, Hughes SA, Beirne DA, Patel PM, Gibbens IM, Bate SC, Thomas K, Eisen TG, Gore ME.
Larkin JM, et al. Among authors: gibbens im.
Br J Cancer. 2007 Jan 15;96(1):44-8. doi: 10.1038/sj.bjc.6603503. Epub 2006 Dec 5.
Br J Cancer. 2007.
PMID: 17146474
Free PMC article.
Clinical Trial.
Item in Clipboard
Sorafenib in advanced melanoma: a Phase II randomised discontinuation trial analysis.
Eisen T, Ahmad T, Flaherty KT, Gore M, Kaye S, Marais R, Gibbens I, Hackett S, James M, Schuchter LM, Nathanson KL, Xia C, Simantov R, Schwartz B, Poulin-Costello M, O'Dwyer PJ, Ratain MJ.
Eisen T, et al. Among authors: gibbens i.
Br J Cancer. 2006 Sep 4;95(5):581-6. doi: 10.1038/sj.bjc.6603291. Epub 2006 Aug 1.
Br J Cancer. 2006.
PMID: 16880785
Free PMC article.
Clinical Trial.
Item in Clipboard
A phase II feasibility study of carboplatin followed by sequential weekly paclitaxel and gemcitabine as first-line treatment for ovarian cancer.
Harries M, Moss C, Perren T, Gore M, Hall G, Everard M, A'Hern R, Gibbens I, Jenkins A, Shah R, Cole C, Pizzada O, Kaye S.
Harries M, et al. Among authors: gibbens i.
Br J Cancer. 2004 Aug 16;91(4):627-32. doi: 10.1038/sj.bjc.6602000.
Br J Cancer. 2004.
PMID: 15238984
Free PMC article.
Clinical Trial.
Item in Clipboard
Combination chemotherapy with carboplatin, capecitabine and epirubicin (ECarboX) as second- or third-line treatment in patients with relapsed ovarian cancer: a phase I/II trial.
Rothermundt C, Hubner R, Ahmad T, Gibbens I, Keyzor C, Habeshaw T, Kaye S, Gore M.
Rothermundt C, et al. Among authors: gibbens i.
Br J Cancer. 2006 Jan 16;94(1):74-8. doi: 10.1038/sj.bjc.6602879.
Br J Cancer. 2006.
PMID: 16306873
Free PMC article.
Clinical Trial.
Item in Clipboard
Attitudes to chemotherapy in patients with ovarian cancer.
Penson RT, Dignan F, Seiden MV, Lee H, Gallagher CJ, Matulonis UA, Olson K, Gibbens I, Gore ME.
Penson RT, et al. Among authors: gibbens i.
Gynecol Oncol. 2004 Aug;94(2):427-35. doi: 10.1016/j.ygyno.2004.05.034.
Gynecol Oncol. 2004.
PMID: 15297184
Item in Clipboard
Cite
Cite